ACADIA 制药 ACAD
$21.23 −$0.01 (-0.05%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.23 0.00%
开盘$21.00
昨收$21.24
当日区间$20.59 – $21.45
成交量1.77M
市值$3.67B
市盈率（TTM）10.0
股息率–
财报
财报日平均波动±6.8%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+14.3%
最差反应-19.5%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±9.6% | +6.08% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±7.1% | +5.03% | 符合区间 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±9.5% | -1.32% | 符合区间 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±12.7% | -3.05% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±10.6% | +2.52% | 符合区间 |
| 2025/Q1 | 7 May 2025 | After Market | ±13.2% | +14.31% | 超出定价预期 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±14.0% | +1.79% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±15.8% | +8.93% | 符合区间 |
| 2024/Q2 | 6 Aug 2024 | After Market | ±20.4% | -19.52% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±17.3% | -11.21% | 符合区间 |
| 2023/Q4 | 27 Feb 2024 | After Market | ±15.3% | -9.92% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±10.3% | +4.70% | 符合区间 |
| 2023/Q2 | 2 Aug 2023 | After Market | ±8.8% | -6.85% | 符合区间 |
| 2023/Q1 | 8 May 2023 | After Market | ±10.3% | -0.56% | 符合区间 |
| 2022/Q4 | 27 Feb 2023 | After Market | ±16.9% | +6.65% | 符合区间 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±21.0% | -6.97% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$307.96M+16.4% YoY
营业利润$37.84M+16.9% YoY
净利润$31.50M+18.1% YoY
摊薄每股收益$0.18+12.5% YoY
自由现金流$95.69M-41.1% YoY
经营现金流$100.78M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率91.1%
营业利润率7.6%
净利率33.4%
净资产收益率35.7%
资产收益率25.6%
投入资本回报率32.0%
流动比率3.39
负债/资产比率25.0%
现金及投资$956.47M
总负债$59.55M
净现金（净负债）$896.93M
自由现金流/营收12.8%
暂无评论——快来第一个聊聊 ACAD。
登录后参与讨论。